From Yahoo Finance: 2025-05-09 04:07:00

Billionaire Larry Robbins’ 10 Stock Picks with Huge Upside Potential list includes Myriad Genetics Inc. (NASDAQ:MYGN). Robbins, founder of Glenview Capital Management, manages capital for investors. The firm’s AUM is $5.6 billion. Glenview Capital had a successful year in 2024 diversifying its investments beyond healthcare stocks. Myriad Genetics is the 2nd stock pick on the list with an 87.35% upside potential.

Myriad Genetics is a molecular diagnostic testing and precision medicine company with a license collaboration with various healthcare centers. In 2024, the company saw 11% revenue growth, driven by its Pharmacogenomics business, particularly the GeneSight test. Myriad is focusing on increasing access to GeneSight through digital engagement and patient payment options. Clinical data supporting GeneSight’s adoption is expected to be published in 2025.

While Myriad Genetics shows promise as an investment, the focus is on AI stocks that offer high returns in a shorter time frame. An AI stock with significant potential and trading at less than 5 times its earnings is highlighted. The article emphasizes the importance of AI stocks in delivering substantial gains.

Read more: Among Billionaire Larry Robbins’ Stock Picks with Huge Upside Potential